RankingsPricing
  1. US-listed companies
  2. DEXCOM INC
  3. Financials
  4. Cash from investing

DEXCOM INCDXCM

Market cap
$25.8B
P/E ratio
SummaryFinancials
Period EndCash from investing (Million USD)YoY (%)
Dec 31, 2024-207-59.09%
Dec 31, 2023-507-2.74%
Dec 31, 2022-521+141.32%
Dec 31, 2021-216-78.77%
Dec 31, 2020-1,018+0.28%
Dec 31, 2019-1,015+626.18%
Dec 31, 2018-140-3.19%
Dec 31, 2017-144+158.32%
Dec 31, 2016-56+8.54%
Dec 31, 2015-51+206.55%
Dec 31, 2014-17-180.38%
Dec 31, 201321-26.41%
Dec 31, 201228-161.25%
Dec 31, 2011-46

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)